|
 |
| home > epc > winter 2001 > improving clinical trial management - moving shipping logistics online |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Clinical trials are both a major financial investment and a risk for pharmaceutical and biotechnology companies. The Boston Consulting Group estimated that when interest and drug failure costs are taken into consideration, the cost of developing a new drug could be as high as US$500 million (1). This cost is primarily driven by the increasingly stringent requirement for companies to satisfy relevant regulatory authorities that the drug being developed is both effective and safe for use in the patient populations for whom it is intended. Clinical trials undertaken to provide this reassurance can vary from single centre studies right up to the multi-centre, global studies with thousands of patients undergoing treatment for several years. This increased tendency for long-term global trials is driven by numerous aspects, including the following:
The need to enrol appropriately 'treatment-naive' patients in a heavily medicalised world
The need to push for subtle improvements over existing therapy
The need to encompass 'outcomes' issues and pharmacoeconomic aspects
The need to check for rare interactions and adverse events
The need to provide data involving populations/countries included in launch plans
The need to provide persuasive evidence to authorities no longer confined to purely medical assessment
The overall increased regulatory hurdles have resulted in a drug development time of 15 years being considered average - from the time of a new chemical entity's discovery in the laboratory to the eventual marketing approval and granting of a product licence (2).
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
3rd Annual Clinical Trial Management Systems (CTMS)
18-19 March 2010, Philadelphia, PA, US
Pharmaceutical and biotech companies are increasingly looking to clinical trial management systems (CTMS) to help streamline their clinical development operations. Building on a successful two-year history, this programme continues to serve as an excellent platform for industry discussion and collaboration among various CTMS stakeholders. This programme addresses the challenges of integrating CTMS systems both within the organisation across various other clinical systems as well as with external systems. Don’t miss this opportunity to hear in-depth industry case studies and learn from the challenges and successes of other companies.
More info >> |
|
 |
News and Press Releases |
 |
Thermo Fisher Scientific Simplifies RNAi Product Selection with New GENEius Product Search Tool
Thermo Fisher Scientific Inc., the world leader in serving science, today announced GENEius Product Search, a tool available on the Thermo Scientific Dharmacon website that helps researchers in the field of RNAi technology easily select the most appropriate gene-specific products for their applications.
More info >> |
|
 |
